IN-PART, a technology company that brings together universities and businesses across the globe, today announced that following successful beta testing, it is launching a new, bespoke scouting service for R&D professionals, called IN-PART: Discover. The new service will revolutionise open innovation by providing companies with novel opportunities for collaboration, specific to their requirements, and often unseen elsewhere.
30 October, 2017
A new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’, has been discovered through an alliance between industry and academia created by Cancer Research UK.
18 October, 2017
A powerful new way of analysing how drugs interact with molecules in the body could aid the design of better treatments with fewer side-effects.
08 October, 2017